Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma-Reference-Cited by-同舟云学术

Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma

Published:2012-12-20 Issue:3 Volume:15 Page:352-359
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Sung K. W.,Lim D. H.,Son M. H.,Lee S. H.,Yoo K. H.,Koo H. H.,Kim J. H.,Suh Y.-L.,Joung Y. S.,Shin H. J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/3/352/3608349/nos304.pdf

Reference30 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. Medulloblastoma: Present Concepts of Stratification into Risk Groups

3. Childhood medulloblastoma

4. Risk-adapted chemotherapy in childhood medulloblastoma

5. Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-Year Trends of Hematopoietic Stem Cell Transplantation in Korean Pediatric Cancer from the National Health Insurance Claims Data;Cancer Research and Treatment;2024-01-15

2. Tandem High-dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors;Cancer Research and Treatment;2023-11-24

3. Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center;Journal of Neuro-Oncology;2023-07-20

4. Le médulloblastome : les dernières avancées majeures;Bulletin du Cancer;2023-04

5. Comorbidity Differences by Trajectory Groups as a Reference for Identifying Patients at Risk for Late Mortality in Childhood Cancer Survivors: Longitudinal National Cohort Study;JMIR Public Health and Surveillance;2023-03-24